Patents by Inventor Alain Robert Michael Townsend

Alain Robert Michael Townsend has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIV-1 core protein fragments
    Patent number: 5700469
    Abstract: The present invention provides peptidal fragments of human immunodeficiency virus (HIV) which interact specifically with a particular human leucocyte antigen (HLA) class I molecule to stimulate cytotoxic T lymphocyte immunity.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 23, 1997
    Assignee: Medical Research Council
    Inventors: Andre James McMichael, Douglas Fraser Nixon, Alain Robert Michael Townsend, Frances Margaret Gotch
  • HIV-1 gag cytotoxic T-lymphocyte epitope and method of use
    Patent number: 5700635
    Abstract: A novel human immunodeficiency virus type 1 (HIV-1) cytotoxic T-lymphocyte (CTL) epitope has been identified in the gag coding region. This epitope corresponds to amino acids 255-269 of Gag and has the following sequence: NH.sub.2 -asn-pro-pro-ile-pro-val-gly-glu-ile-tyr-lys-arg-trp-ile-ile-COOH. This peptide interacts specifically with human leukocyte antigen-B8 (HLA-B8). This peptide is useful for the identification HIV-1 gag-specific CTL.
    Type: Grant
    Filed: December 19, 1994
    Date of Patent: December 23, 1997
    Assignee: United Biomedical, Inc.
    Inventors: Andrew James McMichael, Douglas Fraser Nixon, Alain Robert Michael Townsend
  • Peptide fragments of HIV
    Patent number: 5683701
    Abstract: Peptides are described which have the amino acid sequence of a fragment of HIV (human immunodeficiency virus) which interacts specifically with a particular human leucocyte antigen (HLA) class I molecule, to stimulate cytotoxic T lymphocyte immunity. Such fragments can be used in a potential vaccine against AIDS (acquired immune deficiency syndrome), and for diagnostic and therapeutic purposes.
    Type: Grant
    Filed: December 9, 1994
    Date of Patent: November 4, 1997
    Assignee: United Biomedical, Inc.
    Inventors: Andrew James McMichael, Douglas Fraser Nixon, Alain Robert Michael Townsend